We found that YFD treatment resulted in a substantial increase in CD4<sup>+</sup> and CD8<sup>+</sup> T cells, a reduction in myeloid-derived suppressor cells (MDSCs) and tumor-associated macrophages (TAMs), and an increase in the M1/M2 ratio of TAMs in tumors. The gene discussed is CD8A; the disease is neoplasm.